Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
10/2009
10/21/2009EP2110383A1 Hypoallergenic variants
10/21/2009EP2110382A1 Infectious cDNA of an improved vaccine strain of measles virus, use for immunogenic compositions
10/21/2009EP2110379A2 Mammalian sphingosine kinase type 2 isoforms, and uses thereof
10/21/2009EP2110142A2 Inhibition of secretion from non-neuronal cells
10/21/2009EP2110140A1 Treatment of thromboangiitis obliterans by removal of autoantibodies
10/21/2009EP2110139A2 Method for identifying an anti-myelin associated glycoprotein (MAG) antibody
10/21/2009EP2110138A1 Dosages for treatment of anti-erbB2 antibodies
10/21/2009EP2110137A1 Vaccine against neisseria infection
10/21/2009EP2109667A2 Extracellular matrix cancer vaccine adjuvant
10/21/2009EP2109625A2 Use of antibody conjugates
10/21/2009EP2109624A1 Diagnostic methods for diseases by screening for hepcidin in human or animal tissues, blood or body fluids, monoclonal antibodies specific to human hepcidin and associated uses therefor
10/21/2009EP2109462A1 Antitumor combination comprising a morpholinyl anthracycline and an antibody
10/21/2009EP2109460A1 Anti-kir antibodies, formulations, and uses thereof
10/21/2009EP2109459A1 Archaeal polar lipid aggregates for administration to animals
10/21/2009EP2109458A2 Sugar immunogens
10/21/2009EP2109452A1 Use of a leukocyte diminishing or inactivating agent in combination with bacterially-mediated tumor treatment
10/21/2009EP1654378B1 Methods for chemically synthesizing immunoglobulin chimeric proteins
10/21/2009EP1515724B1 Mitotic kinesin inhibitors
10/21/2009EP1429623B1 Delivery of disease control in aquaculture and agriculture using nutritional feeds containing bioactive proteins produced by viruses
10/21/2009EP1397386B1 Chimeric proteins for cell targeting and apoptosis induction and methods of using the same
10/21/2009EP1392359B1 Specific binding proteins and uses thereof
10/21/2009EP1292680B1 Agonist anti-trk-c monoclonal antibodies
10/21/2009EP1109576B1 Immunogenic beta-propionamido-linked polysaccharide protein conjugate useful as a vaccine produced using an n-acryloylated polysaccharide
10/21/2009EP1047784B1 Neissera meningitidis antigens
10/21/2009EP0986372B1 Vesicular complexes and methods of making and using the same
10/21/2009EP0959899B9 LO-CD2a ANTIBODY AND USES THEREOF FOR INHIBITING T CELL ACTIVATION AND PROLIFERATION
10/21/2009CN101563463A Intergenic sites between conserved genes in the genome of modified vaccinia ankara (MVA) vaccinia virus
10/21/2009CN101563366A Anti-NOTCH3 agonist antibodies and their use in the treatment of NOTCH3-related diseases
10/21/2009CN101563365A Anti-IL-6 monoclonal antibodies and uses thereof
10/21/2009CN101563362A Recombinant HCV E2 glycoprotein
10/21/2009CN101563361A Influenza viruses able to infect canids, uses thereof
10/21/2009CN101563105A Compositions and methods for inhibiting growth of smad4-deficient cancers
10/21/2009CN101563104A Polypeptide-nucleic acid conjugate for immunoprophylaxis or immunotherapy for neoplastic or infectious disorders
10/21/2009CN101563103A Novel nematode protein and its use in producing anthelminthic agents and vaccines
10/21/2009CN101563096A Methods of vaccine administration, new feline caliciviruses, and treatments for immunizing animals against feline paraovirus and feline herpes virus
10/21/2009CN101563090A Use of lipid containing particles comprising quillaja saponins for the treatment of cancer
10/21/2009CN101560520A Japanese encephalitis/dengue chimeric virus and application thereof
10/21/2009CN101560503A Influenza A virus Vero cell adapted strain and application thereof
10/21/2009CN101560500A Cell strain LaDR5 for secreting tumor necrosis factor receptor induced antibody
10/21/2009CN101560496A Dendritic cell carried by tumor stem cell antigen and subjected to tolerance screening, preparation method and application thereof, kit and vaccine comprising dendritic cell
10/21/2009CN101560248A Attenuated enterotoxin C2 superantigen mutant protein, preparation method and application thereof
10/21/2009CN101560247A Mucous membrane immunologic adjuvant using heat-sensitive colitoxin dual-mutant as vaccine
10/21/2009CN101560245A CTL epitope polypeptide of avian influenza H5N1 virus and application thereof
10/21/2009CN101559226A Drug component for preventing and curing pig diarrhea
10/21/2009CN101559225A Meningococcus vaccine
10/21/2009CN101559224A Poliomyelitis vaccine
10/21/2009CN101559223A Idemic encephalitis diphtheria-pertussis-tetanus combined vaccine
10/21/2009CN101559222A Combined vaccine bonding bacterial polysaccharides and protein for human
10/21/2009CN101559221A Binuclear protein reverse transcription colony vaccine against H1N1 influenza A
10/21/2009CN101559220A Controlled live tumor cell vaccine and preparation method and application thereof
10/21/2009CN100551930C Peptides modulating caspase activation
10/21/2009CN100551441C Compositions comprising neisseria meningitidis sero-group B and C and other antigen
10/20/2009US7605248 Recombinant constructs of Borrelia burgdorferi
10/20/2009US7605238 Human CTLA-4 antibodies and their uses
10/20/2009US7605235 Immunoglobulins; Fc receptors; improved antibody-dependent cell mediated cytotoxicity (ADCC); cancer; transgenic animals; host cells
10/20/2009US7605234 Immunoglobulin for use in diagnosis, prevention and treatment of cell proliferative disorders
10/20/2009US7605233 Tumour necrosis factor binding ligands
10/20/2009US7605166 Synergistic mixture of methotrexate and integrin antigen or antibody
10/20/2009US7605138 Nucleic acid compositions for stimulating immune responses
10/20/2009US7605121 Oligopeptide lyophilisate, their preparation and use
10/20/2009US7604989 Prevention or delaying apoptosis in recombinant cell; obtainceks transforme with nucleotide sequences coding antiapoptotic agents, express sequences, monitor adjustment in apotosis activity
10/20/2009US7604973 Lyases; bactericides; gene knockout; animal husbandry; use of nucleic acid segment in the preparation of recombinant cells which produce hyaluronate synthase and its hyaluronic acid product
10/20/2009US7604961 VP1 of foot-and-mouth disease virus
10/20/2009US7604953 Bioamplification for microbial sensor signal transduction
10/20/2009US7604935 Soluble rubella E1 envelope protein variants
10/20/2009US7604821 Fresh water sponge with excipient
10/20/2009US7604811 Inducing an immune response in mammals comprising administering an antigenic synthetic peptide containing Colonization FactorAntigen/I pilus protein T-cell epitopes encapsulated within a biodegradable matrix of glycolic acid-lactic acid copolymer; amino acid sequences; intestinal bioavailability
10/20/2009US7604810 Conserved Neisserial antigens
10/20/2009US7604809 Reinforcing systemic immune responses with lactobacillus casei
10/20/2009US7604808 Circovirus sequences associated with piglet weight loss disease (PWD)
10/20/2009US7604805 Protein logic gates
10/20/2009US7604804 Enhancing anti-HIV efficiency through multivalent inhibitors targeting oligomeric gp120
10/20/2009US7604803 Codelivery to a cell of nucleic acid and assistor protein (antigen) where the nucleic acid encodes an antigenic protein or which shares an epitope(s) with the assistor protein; the nucleic acid is entrapped in liposome intravesicular space; assistor protein is on the liposome surface; synergistic
10/20/2009US7604802 Vaccine composed with protein particle antigen and excipient; especially to elicit cytotoxic-T lymphocyte response.
10/20/2009US7604801 A substantially pure IgE anti-Parvovirus B19 antibody useful for diagnosis and prognosis of parvovirus infected patients by detecting the presence of immunoglobulin E anti-Parvovirus B19 antibodies; antibody-based compositions; viricides
10/20/2009US7604800 Antibodies and their derivatives that induce apoptosis upon binding to P-Selectin Glycoprotein Ligand-1 (PSGL-1) on activatedT cells; autoimmune diseases, transplant rejection, antiallergens, and T cell-derived cancers, anticarinogenic agents;immunosuppressants; induction of immunological tolerance
10/20/2009US7604799 Increasing phosphorylation; decreasing proliferation and/or metastatic behavior; cell lines, antibodies
10/20/2009US7604797 Compositions and methods for treating burns
10/20/2009CA2540279C Hiv vaccine composition
10/20/2009CA2451923C Botulinum toxin in the treatment or prevention of acne
10/20/2009CA2376894C Pharmaceutical composition comprising a protein and an ectoine
10/20/2009CA2341354C Dengue viruses that are replication defective in mosquitos for use as vaccines
10/20/2009CA2250085C Modulators of tnf receptor associated factor (traf), their preparation and use
10/15/2009WO2009126965A2 Compositions, methods and uses for modulations of brca1
10/15/2009WO2009126944A1 Cd37 immunotherapeutic and combination with bifunctional chemotherapeutic thereof
10/15/2009WO2009126934A2 Detection and tratment of pancreatic, ovarian and other cancers
10/15/2009WO2009126920A2 Human serum albumin linkers and conjugates thereof
10/15/2009WO2009126858A2 Materials and methods for improved immunoglycoproteins
10/15/2009WO2009126834A2 Combination of hgf inhibitor and egf inhibitor to treat cancer
10/15/2009WO2009126819A1 Methods for improving the bioactivity of therapeutic ige antibodies for the treatment of disease
10/15/2009WO2009126817A2 Ige antibodies for the treatment of cancer
10/15/2009WO2009126805A2 Therapeutic tarageting of mmps in neutral liposomes
10/15/2009WO2009126725A1 Method of modulating neovascularization
10/15/2009WO2009126719A2 Commensal bacteria as signal mediators within a mammalian host
10/15/2009WO2009126705A2 Induction of tumor hypoxia for cancer therapy
10/15/2009WO2009126698A2 Regulation of fatty acid transporters
10/15/2009WO2009126659A1 Neutralization of gm-csf for the treatment of heart failure
10/15/2009WO2009126648A1 Zona pellucida binding peptides, expression vectors, compositions, and methods for species-specific immunocontraception of animals
10/15/2009WO2009126558A1 Modular method to prepare tetrameric cytokines with improved pharmacokinetics by the dock-and-lock (dnl) technology
10/15/2009WO2009126356A2 Pcv2 mycoplasma hyopneumoniae immunogenic compositions and methods of producing such compositions
1 ... 593 594 595 596 597 598 599 600 601 602 603 604 605 606 607 608 609 610 611 612 613 ... 1823